Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability
- PMID: 15136629
Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability
Abstract
This study was performed to prospectively evaluate fast PET/CT imaging protocols using lutetium oxyorthosilicate (LSO) detector technology and 3-dimensional (3D) image-acquisition protocols.
Methods: Fifty-seven consecutive patients (30 male, 27 female; mean age, 58.6 +/- 15.7 y) were enrolled in the study. After intravenous injection of 7.77 MBq (0.21 mCi) of (18)F-FDG per kilogram, a standard whole-body CT study (80-110 s) and PET emission scan were acquired for 4 min/bed position in 49 patients and 3 min/bed position in 8 patients. One-minute-per-bed-position data were then extracted from the 3- or 4-min/bed position scans to reconstruct single-minute/bed position scans for each patient. Patients were subgrouped according to weight as follows: <59 kg (<130 lb; n = 15), 59-81 kg (130-179 lb; n = 33), and >or=82 kg (>or=180 lb; n = 9). Three experienced observers recorded numbers and locations of lesion by consensus and independently rated image quality as good, moderate, poor, or nondiagnostic.
Results: The observers analyzed 220 reconstructed whole-body PET images from 57 patients. They identified 114 lesions ranging in size from 0.7 to 7.0 cm on the 3- (n = 8) and 4-min/bed position images (n = 49). Of these, only 4 were missed on the 1-min/bed position scans, and all lesions were identified on the corresponding 2-min/bed position images. One- and 2-min/bed position image quality differed significantly from the 4-min/bed position image reference (P < 0.05).
Conclusion: LSO PET detector technology permits fast 3D imaging protocols whereby weight-based emission scan durations ranging from 1 to 3 min/bed position provide similar lesion detectability when compared with 4-min/bed position images.
Similar articles
-
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.J Nucl Med. 2005 Apr;46(4):603-7. J Nucl Med. 2005. PMID: 15809482 Clinical Trial.
-
Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1615-9. doi: 10.1007/s00259-003-1317-8. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14504831
-
Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.J Nucl Med. 2006 Jan;47(1):23-31. J Nucl Med. 2006. PMID: 16391183
-
18F-NaF PET/CT of Obese Patients on a Lutetium-Yttrium Oxyorthosilicate PET/CT System: Patient Dosimetry, Optimization of Injected Activity, and Acquisition Time.J Nucl Med Technol. 2021 Jun;49(2):150-155. doi: 10.2967/jnmt.120.258137. Epub 2020 Dec 30. J Nucl Med Technol. 2021. PMID: 33380519 Review.
-
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.Semin Nucl Med. 2004 Apr;34(2):122-33. doi: 10.1053/j.semnuclmed.2003.12.003. Semin Nucl Med. 2004. PMID: 15031812 Review.
Cited by
-
Decreased imaging time of amyloid PET using [18F]florbetapir can maintain quantitative accuracy.Radiol Phys Technol. 2022 Jun;15(2):116-124. doi: 10.1007/s12194-022-00653-7. Epub 2022 Mar 3. Radiol Phys Technol. 2022. PMID: 35239129
-
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.J Nucl Med. 2015 Jan;56(1):70-5. doi: 10.2967/jnumed.114.148247. Epub 2014 Dec 11. J Nucl Med. 2015. PMID: 25500825 Free PMC article.
-
Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction.Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):291-9. Print 2013. Am J Nucl Med Mol Imaging. 2013. PMID: 23638340 Free PMC article.
-
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.Clin Cancer Res. 2009 Apr 15;15(8):2856-63. doi: 10.1158/1078-0432.CCR-08-2537. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351756 Free PMC article.
-
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.J Nucl Med. 2016 Mar;57(3):420-30. doi: 10.2967/jnumed.115.158808. Epub 2016 Jan 7. J Nucl Med. 2016. PMID: 26742709 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical